Urogen Pharma Ltd (URGN)

Cost of Revenue

$6.57M

Quarterly · Period ending: · USD

URGN logo

URGN Cost of Revenue

Latest reported$6.57M
URGN Quarterly Cost of Revenue ($0.00 → $6.57M)
High-resolution chart · PNG

URGN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
6,572,000
4,139,000
3,289,000
3,278,000
3,550,000
2,330,000
2,471,000
2,453,000
2,229,000
1,728,000
2,286,000
2,367,000
2,443,000
2,265,000
2,263,000
2,020,000
1,846,000
1,525,000
1,589,000
1,244,000
1,427,000
897,000
652,000
309,000
48,000
0
0
23,453,000
0
22,433,000
0
1,055,000
318,000
430,000
287,000
295,000
0
18,000
28,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.